Advertisement 1

Cannabis bankruptcies start to roll in as pandemic halts financing

The weakest companies are succumbing and even relatively healthy firms are showing signs of strain

Article content

The cannabis bankruptcy filings are starting to roll in.

Already plagued by a tough regulatory environment, disappointing sales and capital markets that had closed to all but the strongest companies, the industry is now facing a pandemic-related collapse in stock markets and ever-shrinking financing options. Pot companies completed two capital raises worth just US$5.6 million the week ended March 27, according to data from Viridian Capital Advisors. That’s the lowest level of activity this year and compares to 17 capital raises worth $169 million for the same period in 2019.

Advertisement 2
Story continues below
Article content

The lack of financing is starting to take its toll on the weakest companies. Last week, CannTrust Holdings Inc. and James E. Wagner Cultivation Corp. both filed for bankruptcy protection in Canada. For CannTrust, it was the end of a nine-month-long saga that began when regulators discovered it grew pot in unlicensed areas and ultimately suspended its license, a blow it wasn’t able to recover from.

Article content
Recommended from Editorial
  1. Cannabis for sale inside a store in Ottawa.
    Ontario drops cannabis from list of essential businesses allowed to operate during lockdown
  2. Canadian cannabis company CannTrust Holdings Inc said Tuesday that it had been granted creditor protection under CCAA.
    Cannabis company CannTrust granted creditor protection
  3. Some companies were already running low on cash.
    Global stock meltdown is a disaster for cannabis industry already on the brink

“The effects of the COVID-19 pandemic have exacerbated what were already difficult circumstances,” the company said in a statement, “making it even more challenging for CannTrust to attract new financing or a strategic partner.”

There are other signs of strain, even in relatively healthy companies.

Cronos Group Inc., which is well capitalized thanks to a large investment by tobacco giant Altria Group Inc., delayed the release of its fourth-quarter results and restated its financials for the previous three quarters because of issues with the way it reported certain bulk resin purchases. The company’s weak revenue in the quarter — just US$7.3 million — prompted at least three analysts to downgrade the stock.

Advertisement 3
Story continues below
Article content

Hexo Corp. missed its quarterly filing deadline and, when it did report, announced $266 million of writedowns and impairment charges. Revised debt covenants require it to raise $40 million in equity by April 30, a “startling sum” that “could mean severe downward pressure” on the stock, according to CIBC analyst John Zamparo. If it can’t secure that financing, that “would put its going concern status at risk,” said BMO’s Tamy Chen.

Although cannabis sales jumped as self-isolation orders took effect last month, providing a rare respite for the struggling industry, there are already signs the initial spike is starting to wane.

After a notable increase in mid-March, “sales velocity meaningfully decelerated” on the Ontario Cannabis Store website last weekend, “suggesting that this recent surge may be transitory unless COVID-19 quarantine measures are meaningfully extended,” Chen said in a note. “We believe the COVID-19 fallout presents incremental downside for industry sales over the balance of this year.”

Bloomberg.com

Article content
Comments
You must be logged in to join the discussion or read more comments.
Join the Conversation

Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.

This Week in Flyers